Boothbay Fund Management, LLC Pfizer Inc Call Options Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $1.59 Million - $1.86 Million	62,800 New	62,800 $1.76 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.28 Million - $1.5 Million	40,000 New	40,000 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $9.98 Million - $13 Million	239,000 Added 2042.74%	250,700 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $262,560 - $320,520	6,000 Added 105.26%	11,700 $512,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $646,767 - $766,863	-13,900 Reduced 70.92%	5,700 $299,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $640,500 - $793,660	-14,000 Reduced 41.67%	19,600 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.39 Million - $2.06 Million	33,600 New	33,600 $1.98 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.